Bodycote: Rating Suspended

Research evidence excerpt

Bodycote: Rating Suspended

arances and trading securities held by a research analyst’s account.

Analysts regularly conduct site visits to view the material operations of covered companies, but Barclays policy prohibits them from accepting payment

or reimbursement by any covered company of their travel expenses for such visits.

Barclays Research Department produces various types of research including, but not limited to, fundamental analysis, equity-linked analysis,

quantitative analysis, and trade ideas. Recommendations contained in one type of Barclays Research may differ from those contained in other types of

Barclays Research, whether as a result of differing time horizons, methodologies, or otherwise.

In order to access Barclays Statement regarding Research Dissemination Policies and Procedures, please refer to https://

publicresearch.barclays.com/S/RD.htm. In order to access Barclays Research Conflict Management Policy Statement, please refer to: https://

publicresearch.barclays.com/S/CM.htm.

Primary Stocks (Ticker, Date, Price)

Bodycote (BOY.L, 21-May-2026, GBp 699), Rating Suspended/Neutral, FA/J/K/L/M/N/Q

Other Material Conflicts: Barclays Bank PLC and/or its affiliates is acting as Financial Adviser and Corporate Broker to Bodycote PLC which received a

potential offer from Apollo Management. The rating, price target, and estimates (as applicable) on Bodycote PLC previously issued by the Firm’s

Research department have been temporarily suspended due to this potential transaction.

Unless otherwise indicated, prices are sourced from Bloomberg and reflect the closing price in the relevant trading market, which may not be the last

available closing price at the time of publication.

Disclosure Legend: